Citigroup’s Mural Oncology MURA Stock Holding History

Citigroup’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4	Closed	-$8	–	6321
2025 Q3	$8	Hold	4	–	–	﹤0.01%	5954
2025 Q2	$9	Hold	4	–	–	﹤0.01%	5587
2025 Q1	$5	Sell	4 -1	-20%	-$4	﹤0.01%	5505
2024 Q4	$16	Hold	5	–	–	﹤0.01%	5754
2024 Q3	$16	Sell	5 -103	-95%	-$335	﹤0.01%	5602
2024 Q2	$339	Sell	108 -3,608	-97%	-$13.3K	﹤0.01%	5413
2024 Q1	$18.2K	Buy	3,716 +751	+25%	+$3.65K	﹤0.01%	5059
2023 Q4	$17.6K	Buy	+2,965	New	+$11.9K	﹤0.01%	5031

Citigroup's MURA Position: Q4 2025 in Review

Citigroup sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 4 shares — an estimated $8 sold.

Citigroup first reported a position in MURA in Q4 2023 and held it in 8 quarters. The position peaked at $18.2K in Q1 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Citigroup reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Citigroup sold 4 Mural Oncology shares in Q4 2025, an estimated $8.
Citigroup first reported a position in Mural Oncology in Q4 2023 and held it in 8 quarters.
Citigroup's Mural Oncology position peaked at $18.2K in Q1 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.